Navigation Links
Humphrey GPA Glaucoma Progression Analysys Software

ProductsHumphrey GPA Glaucoma Progression Analysys Software
Company Carl Zeiss Meditec, Inc.
Item Humphrey GPA Glaucoma Progression Analysys Software
Features 
  • Plain language explanations simplify interpretation of test results and help quantify likelihood of progression
  • Based on detailed empirical knowledge of glaucoma acquired in extensive multi-center clinical trials worldwide
  • An advanced, proven method to enhance the management of glaucoma
  • Accurately differentiates clinically significant progression of visual field loss from random variability
  • Automatically identifies clinically significant progression
Description Only Humphrey GPA software accurately differentiates clinically significant progression of visual field loss from random variability, providing an advanced, proven method to enhance management of glaucoma for your patients.

The software applies knowledge acquired from a multi-center clinical trial, in which the actual test/retest variability of hundreds of glaucoma patients was measured. By accurately and objectively identifying progressive visual field loss in glaucoma patients, the Humphrey GPA software assists practitioners in making better treatment decisions.

Info Carl Zeiss Meditec, Inc.Call Carl Zeiss Meditec, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-407-6044

Customer Service: 877-486-7473
Web site: http://www.meditec.zeiss.com/

Related medicine products :

1. Humphrey Matrix
2. Humphrey Field Analyzer II - i series
3. Humphrey FDT Perimeter
4. Humphrey Atlas Corneal Topography Systems
5. Humphrey Refractor/Keratometer HARK 599
6. Model 350 Humphrey Lens Analyzer
7. Model 360 Humphrey Lens Analyzer
8. Humphrey Field Analyzer II - i series
9. Humphrey FDT Visual Field Instrument
10. Humphrey® Field Analyzer/HFA II-i
11. Humphrey Matrix Perimeter
... Interventions, like all important ... successfully guide you to your ... gives you this dependability. So ... on the intervention and not ...
The FLEXI-CUT Directional Debulking System is Abbott Vascular's latest atherectomy catheter designed to enhance performance and ease-of-use....
Tests for protan and deutan defects. Patients must identify numbers or patterns formed in a matrix of small colored dots varying in color and intensity. Two editions available: 38 plate for detailed ...
STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Medicine Products:
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... , ... April 21, 2017 , ... The adage “Show, ... House, the next project in the company’s esteemed VISION House demonstration project series. Manifesting ... exactly the amount of resources they need to live affordably and abundantly without unduly ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The Hong ... the first 3D printing facility among higher education institutions in Hong Kong to support ... in terms of the range and quantity of facilities in Hong Kong. , ...
(Date:4/21/2017)... ... 2017 , ... Alive for Wellness is a group of clinical ... struggles. The Alive team uses advanced behavioral sciences treatment modalities to accomplish their ... mental health struggle is based on 10 modalities of treatment that include: ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured to ... the UK’s most prestigious award for business success. The company has been ... and has grown by a total of 400% over the last six years. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/18/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company founded ... infections, will present preclinical data supporting the use of ... (MDR) Gram-negative infections at the 27th European Congress of ... in Vienna, Austria . ... "Our ongoing preclinical ...
Breaking Medicine Technology: